SVT 2016

Drug Profile

SVT 2016

Alternative Names: SVT-2016

Latest Information Update: 02 May 2007

Price : $50

At a glance

  • Originator SALVAT; University of Barcelona
  • Class Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Osteoarthritis; Pain

Most Recent Events

  • 02 May 2007 Discontinued - Phase-I for Osteoarthritis in Spain (PO)
  • 02 May 2007 Discontinued - Phase-I for Pain in Spain (PO)
  • 19 Dec 2000 SALVAT's COX-2 inhibitor is called SVT 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top